Inflammatory Bowel Disease (IBODI)

INFECTION, IMMUNITY AND ENVIRONMENT
OBJECTIUS

Our objective is to understand the pathophysiology of inflammatory bowel disease and to identify new therapeutic strategies for inflammatory bowel diseases such as Crohn’s disease or Ulcerative Colitis, along with complications derived from these diseases such as perianal fistules. Our group combines basic science with clinical studies for translational research with the aim of improving the quality of life of patients.

RESPONSABLES
  • Dra. Carolina Serena Perelló

  • Presentation
  • Research lines
  • Competitive financing IP and equipment
  • Group members
  • Transfer
  • Dissemination
  • Publications
  • Projects
  • Contact

Inflammatory bowel disease (IMI), including Crohn’s disease and ulcerative colitis, is characterized by recurrent chronic intestinal inflammation. While the etiology of IIM persists to a great extent unknown, it implies a complex interaction between genetic, environmental or microbial factors and immune responses. A more in-depth knowledge of the pathophysiology of IIM may help to identify our therapeutic approaches to cure these maladies. Our group is especially interested in the relationship between the intestinal microbiota, the immunology and the mare adipose cells. The work in progress points out that the perilesional greix contributes to Crohn’s disease, and the translocation of intestinal bacteria that affect the perilesional greix and the interaction of the mare adipose cells and cells of the immune system in these maladies, ens allows to identify useful biomarkers for the diagnosis, prognosis or progression of malaltia.

  • Multi-omnic approach to the search for early predictive biomarkers of response to biological agents in Crohn’s disease.
  • Role of visceral fat in the pathophysiology of inflammatory bowel diseases.
  • New insights into the therapeutic aspect of adipose stem cells: implications for future stem cell therapies in inflammatory bowel disease.
  • Interaction between cellular and molecular mechanisms underlying the development of inflammatory bowel diseases.
  • Host-microbiome interactions: molecular mechanisms in inflammatory bowel diseases.

  • Títol del projecte: Ensayo clínico en Fase IIa para evaluar seguridad y eficacia del tratamiento con células troncales alogénicas mesenquimales derivadas de la grasa en pacientes con estenosis inflamatoria en el contexto de la Enfermedad de Crohn.

    IP: Loles Herreros Marcos

    Membre de l’equip: Carolina Serena

    Agència financiadora: ISCIII (Proyecto de Investigación Clínica Independiente)

    Financiació: 414.172 €.

    Duració (període de financiació): 01/01/2022-31/12/2024

    Expedient projecte: ICI21/0003

  • Títol del projecte: Succinato, un metabolito derivado de la microbiota, marcador de actividad en la Enfermedad de Crohn.

    IP: Margarita Menacho. Co-IP: Carolina Serena.

    Membres de l’equip: Diandra Monfort, Alicia Moliné, Gemma Valldosera.

    Agència financiadora I Beca Clínica GETECCU-Galápagos

    Financiació: 12.000€

    Duració (període de financiació): 01/01/2022-31/12/2022

    Expedient projecte: I Beca Clínica GETECCU-Galápagos

  • Títol del projecte: Peri-lesional adipose tissue (creeping fat) as an immune modulating element of intestinal dysbiosis in Crohn’s disease

    IP: Carolina Serena

    Membres de l’equip: Margarita Menacho, Aleidis Caro, Beatriz Espina.

    Agència financiadora ISCIII

    Financiació: 185.130 €.

    Duració (període de financiació): 01/01/2019-31/12/2022

    Expedient projecte: PI18/00037 (Proyectos de I+D+I en Salud)

  • Títol del projecte internacional: An integrative analysis of DNA methylation and RNA-Seq data in human adipose-stem cells of Crohn’s disease patients with different clinical activity

    IP: Carolina Serena.

    Membre de l’equip: Margarita Menacho

    Agència financiadora: European Crohn’s and Colitis Organization (ECCO).

    Financiació: 50.000 €.

    Duració (període de financiació): 01/01/2019-30/06/2020

    Expedient projecte: ECCO grant 2018 a Carolina Serena

    URL: https://www.ecco-ibd.eu/publications/ecco-news/committee-news/item/ecco-grant-study-synopsis-carolina-serena.html

  • Títol del projecte: A new probiotic strategy to improve metabolic and inflammatory profile in obese patients. SUCCIPRO.

    IP: Isabel Huber

    Membre de l’equip: Carolina Serena

    Agència financiadora Caixaimpulse. Fundación la Caixa.

    Financiació: 70.000 €.

    Duració (període de financiació): 01/01/2019-31/12/2021

    Expedient projecte: SUCCIPRO

  • Títol del projecte: Analyses of the global kinase activities in adipose tissue to find molecular differences resulting from insulin resistance across different clinical phenotypes from lean to obese and type 2 diabetic patients.

    IP: Joan Vendrell / Luis Fajas

    Membre de l’equip: Carolina Serena

    Agència financiadora: La Marató de TV3

    Financiació: 600.000 €.

    Duració (període de financiació): 01/01/2017-01/01/2020

    Expedient projecte: PV17013S

  • Títol del projecte: Mechanistic basis for the distinct inflammatory profile in obese and CD subjects: searching for novel therapeutic approaches

    IP: Carolina Serena.

    Membre de l’equip: Margarita Menacho

    Agència financiadora ISCIII

    Financiació: 159.000 €.

    Duració (període de financiació): 01/01/2016-30/06/2019

    Expedient projecte: PI15/00143 (Proyectos de I+D+I en Salud)

  • Títol del projecte: Antioxidant compounds in inflammation-related metabolic human diseases: in vitro and in vivo.

    IP: Carolina Serena.

    Agència financiadora MINECO

    Financiació: 40.000 €.

    Duració (període de financiació): 23/10/2014-23/10/2018

    Expedient projecte: RYC-2013-13186 (projecte associat al contrate Ramón y Cajal)

  • Títol del projecte: Identification of novel modulators of chronic inflammation in prevalent diseases: unveiling divergent mechanisms of disease (INFLAMES).

    IP: Antonio Zorzano / Joan Vendrell

    Membre de l’equip: Carolina Serena

    Agència financiadora ISCIII

    Financiació: 480.000 €.

    Duració (període de financiació): 01/01/2015-01/01/2018

    Expedient projecte: PIE14/00145 (Proyectos interciber)

  • Propietat industrial i intel·lectual

    Títol: ColonApp_TGN

    Application date: 14/09/2023

    Ref. i-DEPOT Benellux Office: 143375

    Institution: IISPV (HJ23) i GIPSS

    Inventors: Caro, Aleidis; Lahoz, Mari Carmen; Ayala, David

    Modalitat: software

  • S Fernández-Veledo; C Serena; J Vendrell; V Ceperuelo; E Calvo. PCT/EP2019/051157. Targeted interventions directed at reducing the levels of circulating succinate in a subject, and kits and method for determining effectiveness of said interventions. 17/01/2019. IISPV. WO/2019/141780

  • S Fernández-Veledo; C Serena; J Vendrell; A Zorzano. EP17382615.7. Methods for improving the cell therapy efficacy with mesenchymal stem cell populations. 18/09/2017. CIBERDEM.

    Systems biology integration of miR-mRNA profiles identifies steroid refractoriness mechanisms and biomarker candidates in ulcerative colitis

    Ginés, I, Suau, R, Naves, JE, Bernal, C, Clua, L, Lorén, V, Pluvinet, R, Monfort-Ferré, D, Balastegui, ML, Herrero, JFS, Segú-Vergés, C, Aransay, AM, Buschbeck, M, Mañosa, M, Sumoy, L, Serena, C, Domènech, E, Manyé, J. 01/09/2026

    Characterization of mesocolic adipose hyperplasia in a rat 2,4,6-trinitrobenzenesulfonic acid colitis model and comparison to creeping fat in Crohn disease.

    Clua L, Suau R, Guasch M, Monfort-Ferré D, Boronat-Toscano A, Aquino M, Matute-Molina K, Jimeno M, Mañosa M, Sumoy L, Domènech E, Bartolí R, Manyé J, Serena C. 01/04/2026

    Liver fibrosis and type 2 diabetes modulate postprandial incretin and glucagon responses in fatty liver disease.

    Astiarraga B, Rodriguez-Castellano A, Ceperuelo-Mallafré V, Marsal-Beltran A, Osuna-Prieto FJ, Vilanova N, Gracia-Sancho J, Quer JC, Megía A, Balteiro AP, Vendrell J, Fernández-Veledo S. 06/02/2026

    Effect of nicotine on the inflammatory profile of mesenchymal stem cells and mesenteric adipose tissue in Crohn's disease and Ulcerative Colitis

    Mir, IG, Monfort-Ferré, D, Boronat-Toscano, A, Ramirez, N, Caro, A, Menacho, M, Clua, L, Cepero, C, Valldossera, G, Mañas, MJ, Suau, R, Almero, JM, Serena, C. 01/01/2026

    Systems biology-driven miR-mRNA integration identifies potential steroid-refractoriness biomarkers in ulcerative colitis and reveals a conserved mechanism across species

    Mir, IG, Suau, R, Naves, JE, Bernal, C, Clua, L, Monfort-Ferré, D, Pluvinet, R, Herrero, JFS, Segú, C, Aransay, AM, Ciria, MM, Sumoy, L, Serena, C, Moral, ED, Almero, JM. 01/01/2026

    Dialister-driven succinate accumulation is associated with disease activity and postoperative recurrence in Crohn's disease

    Boronat-Toscano, A, Queipo-Ortuño, MI, Monfort-Ferré, D, Suau, R, Vaño-Segarra, I, Valldosera, G, Cepero, C, Astiarraga, B, Clua-Ferré, L, Plaza-Andrade, I, Aranega-Martín, L, Cabrinety, L, de Barbarà, CA, Castellano-Castillo, D, Moliné, A, Caro, A, Domènech, E, Sánchez-Herrero, JF, Benaiges-Fernandez, R, Fernández-Veledo, S, Vendrell, J, Ginés, I, Sumoy, L, Manyé, J, Menacho, M, Serena, C. 07/12/2025

    Use of a New Silver-Impregnated Mesh for Incisional Hernia Surgery With Clean-Contaminated Wounds. First Case Series Results

    Casas, CO, Caro-Tarrago, A, Casanova, R, Vallve-Bernal, M, Farres, C, Ferreres, J, Jorba, R. 29/07/2025

    Elevated Circulating Succinate in Crohn's Disease Correlates with Gut Microbiota Alterations and Inflammatory Activity

    Boronat-Toscano, A, Menacho, M, Monfort-Ferré, D, Valldosera, G, Clua-Ferré, L, Plaza-Andrade,, Arángena-Martín, L, Astiarraga, B, Abadia, C, Cabrinety, L, Moliné, A, Vañó,, Caro, A, Castellano-Castillo, D, Suau, R, Fernández-Veledo, S, Vendrell, J, Manyé, J, Queipo-Ortuño, M, Serena, C. 22/01/2025

    Activation of Adipose Tissue Browning as a Potential Therapeutic Approach to Reduce Inflammation in Crohn's Disease

    Boronat-Toscano, A, Monfort-Ferré, D, Cepero, C, Menacho, M, Clua-Ferré, L, Caro, A, Lahoz, M, Moline, A, Valldosera, G, Suau, R, Mañas, MJ, Manyé, J, Serena, C. 22/01/2025

    OPTI-HEP-D: a protocol for an intervention study comprising screening and linkage to care of people living with hepatitis D in Catalonia

    Palom, A, Rando-Segura, A, Fernandez, G, Calatayud, L, Sellés-Sánchez, A, del Campo, DP, Bayo, SM, Moreno, MMOP, Tabernero, D, Ayats, J, Llopis, MA, Quer, JC, Buti, M. 23/11/2024

    Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles: A focus on inflammatory bowel disease

    Clua-Ferré, L, Suau, R, Vañó-Segarra, I, Ginés, I, Serena, C, Manyé, J. 01/11/2024

    Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry

    Ferreiro-Iglesias, R, Silva, SP, Marín, S, Casanova, MJ, Mañosa, M, González-Muñoza, C, de Francisco, R, Caballol, B, Arias, L, Piqueras, M, Zabana, Y, Rivero, M, Calvet, X, Mesonero, F, Trastoy, PV, Nistal, RB, Perosanz, RG, Vega, P, Gonzalez-Vivo, M, Iborra, M, Bermejo, F, Madero, L, Rodríguez-Lago, I, Gonzalez, MR, Vera, I, Díaz, AP, Vela, M, Medina, LT, Van Domselaar, M, Gomollón, F, Iglesias, E, Gisbert, JP, Calafat, M, Giordano, A, Pérez-Martínez, I, Ricart, E, Sicilia, B, Mena, R, Esteve, M, Rivas, C, Brunet-Mas, E, Fernández, C, Turrión, MAD, Jiménez, BV, Calvo, MQ, Expósito, CR, Márquez-Mosquera, L, Nos, P, Granja, A, Gutiérrez, A, Cabriada, JL, Cruz, DH, Calvo, M, Pérez, JP, Díaz, YR, Casal, DB, Menacho, M, Leal, C, Lucendo, AJ, Royo, V, Olivares, S, Herrero, BA, Carrillo-Palau, M, Alvarez, PG, Marcos, NM, Martínez-Pérez, TD, Villafranca, MCM, Almela, P, Argüelles-Arias, F, Legido, J, Coronel, AMF, Nieto, L, Domènech, E, Acosta, MBD. 01/09/2024

    Genome-wide DNA Methylome and Transcriptome Profiling Reveals Key Genes Involved in the Dysregulation of Adipose Stem Cells in Crohn's Disease

    Monfort-Ferré, D, Boronat-Toscano, A, Sánchez-Herrero, JF, Caro, A, Menacho, M, Vanó-Segarra, I, Martí, M, Espina, B, Pluvinet, R, Cabrinety, L, Abadia, C, Ejarque, M, Nunez-Roa, C, Maymo-Masip, E, Sumoy, L, Vendrell, J, Fernández-Veledo, S, Serena, C. 24/06/2024

    ABDOMINAL WALL RECONSTRUCTION AFTER ILIAC CREST FREE GRAFT

    Olona, C, Rodrigo, M, Díaz, A, Rodríguez, J, Caro, A, Jorba, R. 27/05/2024

    Specialized pro-resolving lipid mediator Resolvin D1 and omega 6 dihomo-?-linolenic acid are unable to solve inflammation in the creeping fat of patients with severe postoperative recurrence in Crohn's disease.

    Suau, R, Pardina, E, Clua, L, Cordobilla, B, Zabana, Y, Calafat, M, Carmona-Maurici, J, Guasch, M, Lorén, V, Ricart-Jané, D, Viñas-Calaf, A, Fluvià, L, Aguilar, R, Mañosa, M, Dobaño, C, Hernández, JM, López-Tejero, MD, Domingo, JC, Domènech, E, Serena, C, Manyé, J. 01/01/2024

    Development of a novel experimental model for studying creeping fat in Crohn's Disease

    Clua, L, Suau, R, Guasch, M, Monfort-Ferré, D, Vañó, I, Serena, C, Domènech, E, Bartolí, R, Manyé, J. 01/01/2024

    Inflammatory Environment-Induced Transcriptomic Alterations in Crohn's Disease Adipose Stem Cells

    Montfort-Ferré, D, Boronat-Toscano, A, Sánchez-Herrero, JF, Caro, A, Menacho, M, Vañó-Segarra, I, Martí, M, Espina, B, Pluvinet, R, Cabrinety, L, Abadia, C, Ejarque, M, Nuñez-Roa, C, Maymo-Masip, E, Sumoy, L, Vendrell, J, Fernández-Veledo, S, Serena, C. 01/01/2024

    NOD2 and Beyond: Unmasking Tobacco-Induced Epigenetic Changes in Crohn's Disease

    Vañó, I, Ferre, DM, Toscano, AB, Menacho, M, Valldosera, G, Caro, A, Ferre, LC, Suau, R, Manye, J, Serena, C. 01/01/2024

    Effects of Anti-TNF Treatment on Browning of Mesenteric Adipose Tissue with Crohn's Disease

    Montfort-Ferré, D, Vaño-Segarra, I, Boronat-Toscano, A, Menacho, M, Moliné, A, Cepero, C, Mañas, MJ, Caro, A, Serena, C. 01/01/2024

    Randomised clinical trial to test the phenolization in sacrococcygeal pilonidal disease

    Lopez, JE, Perez, JE, Mallafre, RS, Villaro, FF, Tarrago, AC, Perez, BE, Serafini, JF, Martin, RJ. 01/08/2023

    Micro-elimination of chronic hepatitis C virus in patients with psychiatric disorders: a multidisciplinary strategy in the outpatient mental health center

    de Miera, IS, López, J, Royo, M, Plo, I, Rodríguez, A, Montoliu, S, Pardo, A, Ruiz, J, Boniquet, JCQ. 01/06/2023

    Effectiveness of a direct care action strategy at the drug addiction center (test and treat in point of care) for the detection and treatment of hepatitis C in drug users on opioid agonist substitution therapy

    Rodríguez, A, de Miera, IS, Sendra, MA, Méndez, P, Roch, MA, Vargas, M, Montoliu, S, Pardo, A, Colom, J, Boniquet, JCQ. 01/06/2023

    Smoking Suppresses the Therapeutic Potential of Adipose Stem Cells in Crohn's Disease Patients through Epigenetic Changes

    Boronat-Toscano, A, Vañó, I, Monfort-Ferré, D, Menacho, M, Valldosera, G, Caro, A, Espina, B, Mañas, MJ, Marti, M, Espin, E, Saera-Vila, A, Serena, C. 01/04/2023

    Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study)

    Serra-Aracil, X, Pericay, C, Badia-Closa, J, Golda, T, Biondo, S, Hernandez, P, Targarona, E, Borda-Arrizabalaga, N, Reina, A, Delgado, S, Vallribera, F, Caro, A, Gallego-Plazas, J, Pascual, M, alvarez-Laso, C, Guadalajara-Labajo, HG, Mora-Lopez, L. 01/01/2023

    The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's Disease

    Iborra, M, Moret, I, Busó, E, García-Giménez, JL, Ricart, E, Gisbert, JP, Cabré, E, Esteve, M, Márquez-Mosquera, L, García-Planella, E, Guardiola, J, Pallardo, FV, Serena, C, Algaba-Chueca, F, Domenech, E, Nos, P, Beltrán, B. 01/12/2022

    The Gut Microbiota Metabolite Succinate Promotes Adipose Tissue Browning in Crohn's Disease

    Monfort-Ferré, D, Caro, A, Menacho, M, Martí, M, Espina, B, Boronat-Toscano, A, Nuñez-Roa, C, Seco, J, Bautista, M, Espín, E, Megía, A, Vendrell, J, Fernández-Veledo, S, Serena, C. 01/11/2022

    Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn's Disease

    Boronat-Toscano, A, Monfort-Ferré, D, Menacho, M, Caro, A, Bosch, R, Espina, B, Algaba-Chueca, F, Saera-Vila, A, Moliné, A, Marti, M, Espin, E, Millan, M, Serena, C. 01/10/2022

    Glycogen accumulation in adipocyte precursors from elderly and obese subjects triggers inflammation via SIRT1/6 signaling

    Terrón-Puig, M, Huber-Ruano, I, Sabadell-Basallote, J, Ejarque, M, Núñez-Roa, C, Maymó-Masip, E, Jorba, R, Serena, C, Vendrell, J, Fernández-Veledo, S. 01/08/2022

    Noninferiority multicenter prospective randomized controlled study of rectal cancer T2-T3s (superficial) N0, M0 (T2T3sN0M0) undergoing neoadjuvant treatment and local excision (TEM) versus total mesorectal excision (TME): Preoperative, surgical, and pathological outcomes-The TAUTEM-study.

    Serra-Aracil, X, Pericay, C, Badia-Closa, J, Golda, T, Biondo, S, Hernández, P, Tarragona, E, Borda-Arrizabalaga, N, Reina, A, Delgado, S, Vallribera, F, Caro, A, Plazas, JG, Pascual, M, Alvarez-Laso, C, Garcia, D, Mora-López, L. 01/06/2022

    Mn(II) Complexes of Enlarged Scorpiand-Type Azamacrocycles as Mimetics of MnSOD Enzyme

    Inclan, M, Albelda, MT, Blasco, S, Serena, C, Chicote, JU, Garcia-Espana, A, Garcia-Espana, E. 01/03/2022

    An integrative analysis of DNA methylation and RNA-Seq data in human adipose-stem cells of Crohn's Disease patients with different clinical activity

    Serena, C, Montfort-Ferré, D, Caro, A, Menacho, M, Espina, B, Boronat-Toscano, A, Martí, M, Espín, E, Millán, M, Vendrell, J, Fernández-Veledo, S. 01/01/2022

    Succinate promotes the conversion from white to beige adipose tissue in Crohn's Disease

    Montfort-Ferré, D, Menacho, M, Caro, A, Espina, B, Boronat-Toscano, A, Nuúez-Roa, C, Martí, M, Espin, E, Vendrell, J, Fernández-Veledo, S, Serena, C. 01/01/2022

  • Title: 2022 FI_B 00577 AGAUR SOL·LICITUD D'AJUTS PER A LA CONTRACTACIO DE PERSONAL INVESTIGADOR PREDOCTORAL EN FORMACIO ( FI 2022 ) CANDIDAT: ALBERT BORONAT TOSCANO NUMERO ORCID 0000-0003-2650-156X – PV22018S

    Funding entity: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duration: 2022-2025

    Principal Investigator: BORONAT TOSCANO , ALBERT

  • Title: 2021 SGR 01116 GRUP DE RECERCA CONSOLIDAT (GRC) OPCIO RECONEIXEMENT SENSE FINANÇAMENT (VALIDACIO TECNICA) IISPV – PV23057S

    Funding entity: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duration: 2022-2025

    Principal Investigator: SERENA PERELLO, CAROLINA

  • Title: PID2023-146315OB-I00 VESICULAS EXTRACELULARES TOLEROGENICAS DE CELULAS MADRE PARA RESTAURAR EL PAPEL PROTECTOR DEL TEJIDO ADIPOSO MESENTERICO EN LA INFLAMACION INTESTINAL EN LA ENFERMEDAD DE CROHN (CROHN’S CARE) – PROYECTOS DE GENERACION DEL CONOCIMIENTO 2023 – PV24096S

    Funding entity: AGENCIA ESTATAL DE INVESTIGACION

    Duration: 2024-2027

    Principal Investigator: SERENA PERELLO, CAROLINA

  • Title: PI24/00151 RESTAURACION DE LA HOMEOSTASIS INTESTINAL EN LA ENFERMEDAD DE CROHN MEDIANTE LA IMPLANTACION DE UNA MATRIZ 3D CON VESICULAS EXTRACELULARES EN EL TEJIDO ADIPOSO PERILESIONAL – PV24124S

    Funding entity: INSTITUTO CARLOS III

    Duration: 2025-2025

    Principal Investigator: SERENA PERELLO, CAROLINA

  • Title: DONACION: L’AJUT PER A LA INICIACIO A LA RECERCA DE LA SOCIETAT CATALANA DE DIGESTIOLOGIA ACMB – PV25019S

    Funding entity: FUNDACIO PRIVADA ACADEMIA CMSCB

    Duration: 2025-2025

    Principal Investigator: SERENA PERELLO, CAROLINA

  • Title: 2025 PROD 00210_AJUTS D'INDUSTRIA DEL CONEIXEMENT_MODALITAT B. PRODUCTE_MATRIU 3D ENRIQUIDA AMB VESICULES EXTRACEL·LULARS COM A TERAPIA INNOVADORA PER A LA MALALTIA DE CROHN (VESICLEX). – PV25093S

    Funding entity: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duration: 2025-2027

    Principal Investigator: SERENA PERELLO, CAROLINA

  • Title: AYUDAS A LA FORMACION DE PERSONAL NO MEDICO DEDICADO A TAREAS DE INVESTIGACION EN EL EII ADACYTE-GETECCU – PV26021S

    Funding entity: GRUPO ESPAÑOL DE TRABAJO EN ENFERMEDAD DE CROHN Y COLITIS UL

    Duration: 2026-2026

    Principal Investigator: SERENA PERELLO, CAROLINA

Membres De L’equip